274 related articles for article (PubMed ID: 11910749)
1. [Advances in in vitro refolding of inclusion body proteins].
Fang M; Huang HL
Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):608-12. PubMed ID: 11910749
[TBL] [Abstract][Full Text] [Related]
2. Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies.
Misawa S; Kumagai I
Biopolymers; 1999; 51(4):297-307. PubMed ID: 10618597
[TBL] [Abstract][Full Text] [Related]
3. Direct refolding of inclusion bodies using reversed micelles.
Sakono M; Kawashima YM; Ichinose H; Maruyama T; Kamiya N; Goto M
Biotechnol Prog; 2004; 20(6):1783-7. PubMed ID: 15575712
[TBL] [Abstract][Full Text] [Related]
4. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli.
Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102
[TBL] [Abstract][Full Text] [Related]
5. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli.
Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK
Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894
[TBL] [Abstract][Full Text] [Related]
6. Estimating the potential refolding yield of recombinant proteins expressed as inclusion bodies.
Ho JG; Middelberg AP
Biotechnol Bioeng; 2004 Sep; 87(5):584-92. PubMed ID: 15352056
[TBL] [Abstract][Full Text] [Related]
7. Isolation and renaturation of bio-active proteins expressed in Escherichia coli as inclusion bodies.
Fischer B; Sumner I; Goodenough P
Arzneimittelforschung; 1992 Dec; 42(12):1512-5. PubMed ID: 1288517
[TBL] [Abstract][Full Text] [Related]
8. Anti-aggregatory effect of cyclodextrins in the refolding process of recombinant growth hormones from Escherichia coli inclusion bodies.
Bajorunaite E; Cirkovas A; Radzevicius K; Larsen KL; Sereikaite J; Bumelis VA
Int J Biol Macromol; 2009 Jun; 44(5):428-34. PubMed ID: 19428477
[TBL] [Abstract][Full Text] [Related]
9. Matrix-assisted refolding of oligomeric small heat-shock protein Hsp26.
Franzmann TM
Int J Biol Macromol; 2006 Aug; 39(1-3):104-10. PubMed ID: 16626802
[TBL] [Abstract][Full Text] [Related]
10. A novel "reverse screening" to identify refolding additives for activin-A.
Ejima D; Ono K; Tsumoto K; Arakawa T; Eto Y
Protein Expr Purif; 2006 May; 47(1):45-51. PubMed ID: 16226036
[TBL] [Abstract][Full Text] [Related]
11. [In vitro renaturation of proteins from inclusion bodies].
Porowińska D; Marszałek E; Wardęcka P; Komoszyński M
Postepy Hig Med Dosw (Online); 2012 Jun; 66():322-9. PubMed ID: 22706118
[TBL] [Abstract][Full Text] [Related]
12. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
Vallejo LF; Rinas U
Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
[TBL] [Abstract][Full Text] [Related]
13. On-column refolding of recombinant human interleukin-4 from inclusion bodies.
Razeghifard MR
Protein Expr Purif; 2004 Sep; 37(1):180-6. PubMed ID: 15294296
[TBL] [Abstract][Full Text] [Related]
14. Renaturation of recombinant human neurotrophin-3 from inclusion bodies using a suppressor agent of aggregation.
Suenaga M; Ohmae H; Tsuji S; Itoh T; Nishimura O
Biotechnol Appl Biochem; 1998 Oct; 28 ( Pt 2)():119-24. PubMed ID: 9756741
[TBL] [Abstract][Full Text] [Related]
15. Inclusion body anatomy and functioning of chaperone-mediated in vivo inclusion body disassembly during high-level recombinant protein production in Escherichia coli.
Rinas U; Hoffmann F; Betiku E; Estapé D; Marten S
J Biotechnol; 2007 Jan; 127(2):244-57. PubMed ID: 16945443
[TBL] [Abstract][Full Text] [Related]
16. Technical refolding of proteins: Do we have freedom to operate?
Eiberle MK; Jungbauer A
Biotechnol J; 2010 Jun; 5(6):547-59. PubMed ID: 20518058
[TBL] [Abstract][Full Text] [Related]
17. In vitro refolding of heterodimeric CapZ expressed in E. coli as inclusion body protein.
Remmert K; Vullhorst D; Hinssen H
Protein Expr Purif; 2000 Feb; 18(1):11-9. PubMed ID: 10648164
[TBL] [Abstract][Full Text] [Related]
18. A high-throughput protein refolding screen in 96-well format combined with design of experiments to optimize the refolding conditions.
Dechavanne V; Barrillat N; Borlat F; Hermant A; Magnenat L; Paquet M; Antonsson B; Chevalet L
Protein Expr Purif; 2011 Feb; 75(2):192-203. PubMed ID: 20851186
[TBL] [Abstract][Full Text] [Related]
19. Protein expression and refolding--a practical guide to getting the most out of inclusion bodies.
Cabrita LD; Bottomley SP
Biotechnol Annu Rev; 2004; 10():31-50. PubMed ID: 15504702
[TBL] [Abstract][Full Text] [Related]
20. High pH solubilization and chromatography-based renaturation and purification of recombinant human granulocyte colony-stimulating factor from inclusion bodies.
Li M; Fan H; Liu J; Wang M; Wang L; Wang C
Appl Biochem Biotechnol; 2012 Mar; 166(5):1264-74. PubMed ID: 22212394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
